Biochem Biophys Res Commun 2004
Options may include SGLT2 inhibitors, metformin, thiazolidinediones, or insulin for diabetes, noting that DPP-4 inhibitors also carry pancreatitis warnings
Clinical trial data show it helps 37% of people lose at least 5% of their starting body weight in 12 weeks
Zhou J, Zheng Y, Xu B et al (2024) Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database
GLP-1 (Glucagon-like peptide-1) is a powerful gut hormone released when eating thats critical for metabolism, blood sugar control, and weight management
Many systemic inflammatory conditions have gastrointestinal components that benefit from this approach